Clinically Significant Prostate Cancer Diagnosis Without Histological Proof: A Possibility in the Prostate-specific Membrane Antigen Era?

Magnetic resonance imaging (MRI) has resulted in a reduction in the number of patients indicated for prostate biopsy. Prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) has recently shown additional value in detecting clinically significant prostate c...

Descripción completa

Detalles Bibliográficos
Autores principales: Heetman, Joris G., Wever, Lieke, Paulino Pereira, Leonor J., van den Bergh, Roderick C.N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Open Horizon
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421196/
https://www.ncbi.nlm.nih.gov/pubmed/36046616
http://dx.doi.org/10.1016/j.euros.2022.06.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421196/
https://www.ncbi.nlm.nih.gov/pubmed/36046616
http://dx.doi.org/10.1016/j.euros.2022.06.013

Ejemplares similares